You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Obesity

Semaglutide for managing overweight and obesity

  • Technology appraisal guidance
  • Reference number: TA875
  • Published:  08 March 2023
  • Last updated:  04 September 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Case studies
  2. Resource impact
  3. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Case studies

  • Injectable anti-obesity medications in specialist weight management services: supporting people with complex needs

Resource impact

  • Resource impact template (Excel 2.38 MB)

    Published:
    02 June 2025
  • Resource impact template and summary report

  • Resource impact summary report

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top